Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemiaQianyi Zhou, Hairong Lyu, Xiaomei Zhang et al.|Frontiers in Immunology|2025Cited by 7